Moderna Inc.’s stock soared 14% early Thursday to early Friday after the biotech company and partner Merck & Co. announced positive data from a trial of Moderna’s mRNA-4157 in combination with Merck’s blockbuster cancer drug Keytruda in patients with resected high-risk melanoma (stage III/IV). The companies said that after about three years, the combination...
MRNA is not looking too good. What we can see is a weekly bearish engulfing candle after clear rejection from the upsloping resistance line. Rejection was nasty therefore we're seeing instant follow through. You can short it now with a final target at the support which is the entry for longs too. At the support, flip bullish and take a long position. The target...
There is a daily wolfe wave setup that triggered on December 15. Today at the open, MRNA opened inside day and traded +4% within 30 mins of the trading day. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line; however, the linear lines do not converge. The projected target is approx 167 which is...
HELLO GUYS THIS MY IDEA 💡ABOUT MRNA is nice to see strong volume area.... Where is lot of contract accumulated.. I thing that the buyers from this area will be defend this LONG position.. and when the price come back to this area, strong buyers will be push up the market again.. UP TREND + Resistance from the past + Strong volume area is my mainly reason for...
We all know this stock saw a large rise due to world conditions over the last few years, but since that has mostly come to and end, it's time to let MRNA rest for a while. This looks like a massive Head & Shoulders if I've ever seen one, this could bring price as far down as $30, but more than likely will find some major support at below $90 in the medium term....
Moderna Short Term We look to Sell at 183.71 (stop at 203.39) Preferred trade is to sell into rallies. Previous resistance located at 190.00. Trading within a Bearish Channel formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be...
Moderna, Inc. ( NASDAQ:MRNA ) Sector: Health Technology (Biotechnology) Market Capitalization: $74.178B Current Price: $186.49 Breakout Price: $189.50 Buy Zone (Top/Bottom Range): $180.95-$147.05 Price Target: $204.50-$208.80 (1st), $258.80-$263.70 (2nd) Estimated Duration to Target: 34-37d, 91-96d Contract of Interest: $MRNA 9/16/22 190c, $MRNA 10/21/22...
Moderna Short Term We look to Sell at 146.42 (stop at 154.23) Preferred trade is to sell into rallies. Price action has posted a bearish Shooting Star and is negative for short-term sentiment. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look...
Moderna Short Term We look to Sell at 133.52 (stop at 141.88) Preferred trade is to sell into rallies. Prices expected to stall near trend line resistance. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our...
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
Moderna - Short Term - We look to Sell a break of 137.05 (stop at 147.24) A move through bespoke support at 140.00 and we look for extended losses. Closed below the 20-day EMA. The primary trend remains bearish. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 108.99 and...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). And recently we have seen it fall back to a very cheap price than it was back in 2 August 2021, In its current position we look to buy shares on MRNA as it is currently in a demand level.
MRNA Looking good for a OMICRON catalyst. Its a runner! PT's are subjective. This is not financial advice! Trade with caution & patience, but enjoy.
Aspen Trading S/R levels are showing resistance @ 345. MRNA has been trading choppy between a range and now it is at the top end of the range. It looks bearish in short-term. Please like, share and follow if you agree with the analysis. Note - Aspen Trading S/R levels are invite only. They can be accessed through my profile information. Disclaimer: This...
SNIPER STRATEGY (new version) It works ALMOST ON ANY CHART. It produces Weak, Medium and Strong signals based on consisting elements. NOT ALL TARGETS CAN BE ACHIEVED, let's make that clear. TARGETS OR ENTRY PRICES ARE STRONG SUPPORT AND RESISTANCE LEVELS. ENTRY PRICE BLACK COLOR TARGETS GREEN COLOR STOP LOSS RED COLOR DO NOT USE THIS...
SNIPER STRATEGY This magical strategy works like a clock on almost any charts Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading. It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave. The best timeframe for this strategy is Daily, Weekly and Monthly...
Analysis on hourly, so probably good setup for tomorrow. Looking at entering short at around ema 9/session vwap 425 level. Taking it to next local support at the 407-410 strip, probably good to close there as the ema 20 on the 4 hour at 413, so probably just dive through it and finish above it. So short quick trade could be nice here. This stock is a wild animal...
On 7/15/2021 Jefferies Financial Group brokerage Boosted the Price Target from Positive to Hold from $170.00 to $250.00 On 5/7/2021 Morgan Stanley brokerage Lowered the Price Target to Equal Weight from $201.00 to $190.00 On 5/7/2021 The Goldman Sachs Group brokerage Boosted the Price Target to Buy from $206.00 to $228.00 My price target for MRNA is the Fib...